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Anodal transcranial direct 
current stimulation over the left 
dorsolateral prefrontal cortex 
modulates attention and pain in 
fibromyalgia: randomized clinical 
trial
Adriana Ferreira Silva1, Maxciel Zortea1,2, Sandra Carvalho3,4, Jorge Leite  3,4, Iraci Lucena da 
Silva Torres1,5, Felipe Fregni3 & Wolnei Caumo1,2,5,6,7
Cognitive dysfunction in fibromyalgia patients has been reported, especially when increased attentional 
demands are required. Transcranial direct current stimulation (tDCS) over the dorsolateral prefrontal 
cortex (DLPFC) has been effective in modulating attention. We tested the effects of a single session 
of tDCS coupled with a Go/No-go task in modulating three distinct attentional networks: alertness, 
orienting and executive control. Secondarily, the effect on pain measures was evaluated. Forty females 
with fibromyalgia were randomized to receive active or sham tDCS. Anodal stimulation (1 mA, 20 min) 
was applied over the DLPFC. Attention indices were assessed using the Attention Network Test (ANT). 
Heat pain threshold (HPTh) and tolerance (HPTo) were measured. Active compared to sham tDCS led 
to increased performance in the orienting (mean difference [MD] = 14.63) and executive (MD = 21.00) 
attention networks. There was no effect on alertness. Active tDCS increased HPTh as compared to 
sham (MD = 1.93) and HPTo (MD = 1.52). Regression analysis showed the effect on executive attention 
is mostly independent of the effect on pain. DLPFC may be an important target for neurostimulation 
therapies in addition to the primary motor cortex for patients who do not respond adequately to 
neurostimulation therapies.
Fibromyalgia (FM) is a chronic and widespread musculoskeletal pain disorder that commonly manifests itself 
as body stiffness, fatigue, sleep disorders, anxiety, depression, with a highly subjective pain catastrophizing1. An 
important mechanism involved in its physiopathology is an excessive cortical facilitation (a lack of inhibition)2, 
which has been associated with a lower pain threshold, and a higher level of trait anxiety3, 4. It is thought that FM 
is related to abnormal information across the afferent pathways to the brain that, due to the phenomenon of cen-
tral sensitization, changes the brain sensory processing, which in turn leads to the chronic sensation of pain. This 
process involves regions defined as the pain neuromatrix, which consists of the frontal lobe, anterior cingulate 
cortex (ACC), insula, amygdala, hypothalamus, periaqueductal gray (PAG), nucleus cuneiformis (NCF), and 
rostral ventromedial medulla (RVM)5.
1Post Graduate Program in Medical Sciences, School of Medicine, Federal University of Rio Grande do Sul, Porto 
Alegre, Brazil. 2Laboratory of Pain & Neuromodulation, Clinical Hospital of Porto Alegre, Porto Alegre, Brazil. 
3Spaulding Center of Neuromodulation, Department of Physical Medicine and Rehabilitation, Harvard Medical 
School, Boston, Massachusetts, USA. 4Neuropsychophysiology Laboratory, CIPsi, School of Psychology (EPsi), 
University of Minho, Braga, Portugal. 5Pharmacology Department, Institute of Basic Health Sciences, Federal 
University of Rio Grande do Sul, Porto Alegre, Brazil. 6Pain and Palliative Care Service, Clinical Hospital of Porto 
Alegre, Porto Alegre, Brazil. 7Surgery Department, School of Medicine, Federal University of Rio Grande do Sul, Porto 
Alegre, Brazil. Correspondence and requests for materials should be addressed to W.C. (email: caumo@cpovo.net)
Received: 5 January 2017
Accepted: 13 February 2017
Published: xx xx xxxx
OPEN
www.nature.com/scientificreports/
2Scientific RepoRts | 7: 135  | DOI:10.1038/s41598-017-00185-w
In addition to pain, cognitive impairments are reported in more than 70% of subjects with FM6, 7. Overall, 
subjects with FM show deficits in tasks requiring working memory, attention, conflict monitoring and verbal 
fluency8. Despite the fact that there is mixed evidence about attentional impairments in patients with FM9, several 
studies have demonstrated that subjects with FM have impaired attention in tasks involving competing informa-
tion, reduced vigilance as showed by slower reaction time; and greater alertness as showed by greater reduction in 
errors after warning cues8, 10. Moreover, these attention deficits have been associated with other clinical symptoms 
such as sleep quality, anxiety and depression levels, and pain catastrophizing8.
The attention network model11 separates it into three components: Alerting is the achievement and mainte-
nance of an alert state. Orienting refers to the selection and use of a stimulus from the sensory system. Finally, 
Executive control of attention deals with conflicting information to give a response. This relative independent 
component of attention can be measured separately using the Attention Network Test (ANT)12. Alerting atten-
tion is supposed to be processed by the thalamus and involves activation of anterior and posterior cortical sites. 
Orienting attention tends to activate superior parietal locations and pre-central gyrus, which is closely related to 
frontal eye fields. Anterior cingulate and other cortical left and right frontal areas are activated when Executive 
control of attention is performed13. This anatomo-clinical relationship creates an opportunity to investigate the 
effect of non-invasive brain stimulation techniques, such as transcranial direct current stimulation (tDCS).
tDCS is a safe, painless and effective non-invasive brain stimulation technique that is able to neuromodulate 
cortical areas by decreasing (anodal stimulation) or increasing (cathodal stimulation) neuronal firing threshold14. 
Indeed, in healthy subjects tDCS over the dorsolateral prefrontal cortex (DLPFC) increased pain threshold15 and 
in patients with fibromyalgia it relieved chronic pain16, 17. This technique has been effectively used to enhance 
cognitive functions, in both healthy18–20 and clinical populations21, 22. Regarding cognitive function, recent find-
ings suggest that the effects of tDCS can be boosted in association with a task23. The underlying mechanism is the 
neuronal long-term potentiation (LTP), in which a strong synaptic stimulation can lead to a strengthening of the 
synaptic transmission.
The DLPFC is an important brain region for emotional processing and down regulation of affective conditions 
such as pain and plays an important role in several cognitive processes, such as cognitive flexibility, working 
memory, and planning24. To enhance the effects of tDCS over the DLPFC, a combined task should recruit the 
functioning of this area. The Go/No-go Task is known for requiring attention and the inhibition of a response 
when certain conditions are presented. Moreover, the performance on this task is related to the functioning of 
prefrontal areas, including the DLPFC25. Even though most of FM patients show attentional impairments, little is 
known about the effects of attentional processing modulation on pain perception in these patients. Nevertheless, 
there is some evidence from healthy subjects that top-down attentional processes are involved in nociceptive 
modulation26.
Here, we investigate the effects of tDCS over the DLPFC coupled with a Go/No-go Task in modulating three 
distinct attentional networks: alert, orienting and executive control. We hypothesize that the active (a)-tDCS, as 
compared to sham, will lead to significant changes in attention performance. In addition, the neuromodulation of 
one component of the pain neuromatrix will also lead to changes in pain measurements.
Results
Patient characteristics. The clinical and demographic characteristics of the subjects according to the 
sequence allocation were comparable and are shown in Table 1. Twenty patients were allocated according to 
the sequence Sham-Active Group, and twenty were assigned to the sequence Active-Sham Group. Two subjects 
were excluded because they did not reliably understand the experiment procedures and instructions and two 
other subjects were excluded due to extreme internal variability in pain measures and the ANT task. In the group 
receiving sham first, one subject dropped out without a justification reported. Thirty-five subjects completed the 
study. Minor side effects (i.e. tingling, burning and itching) were presented by 33.33% (13/39) of subjects in the 
s-tDCS condition and 27.5% (11/40) in the a-tDCS condition. No major side effects were observed, and only 
13.2% of subjects were able to correctly guess the intervention received.
Primary outcome: anodal tDCS over left DLPFC effects on ANT measures. We first analyzed 
Alerting, Orienting and Executive Attention indices using linear mixed models, considering two factors: Group 
(a-tDCS and s-tDCS) and Phase (first and second). For the Alerting index, no significant differences between 
Group, F(1, 66.24) = 0.953; P = 0.33, and Phase, F(1, 66.24) = 0.696; P = 0.40, were found, and no interaction was 
found, F(1, 66.24) = 0.989; P = 0.324 (Fig. 1A). For the Orienting index, there was a significant effect of Group, 
F(1, 70.0) = 4.189; P = 0.044, and no Phase effect, F(1, 69.18) = 0.145; P = 0.705. Although the interaction was 
not significant, F(1, 69.18) = 1.138; P = 0.290, groups differed only after the second crossover phase (p = 0.032), 
favoring the active group (M = 62.5; SE = 10.1) compared to sham group (M = 31.2; SE = 9.6), considering a Least 
Significant Difference (LSD) posthoc pairwise comparison (Fig. 1B). Finally, the Executive index showed a main 
effect for Group, F(1, 49.11) = 7.94; p = 0.007, and no effect of Phase, F(1, 50.53) = 0.014; p = 0.907. Although no 
significant interaction was found, F(1, 50.53) = 0.005; p = 0.946, a pairwise comparison (LSD posthoc) showed 
that only for Phase 2 (p = 0.013) the active tDCS group had less influence of the incongruent target (M = 83.2; 
SE = 10,2) than the sham group (M = 120.8; SE = 10,2, Fig. 1C). Table 2 presents group comparisons for the ANT 
scores differences between phases (first and second).
Additionally, we ran mixed linear model analyses for each of the Cues vs. Target conditions (except for neutral 
targets, due to its similarity with the congruent target conditions12), considering only main effects for Group, 
which is the factor of most interest. The a-tDCS group showed significantly better performance than the s-tDCS 
group in the congruent target conditions when there was no cue and spatial cue. Table 3 presents this data.
www.nature.com/scientificreports/
3Scientific RepoRts | 7: 135  | DOI:10.1038/s41598-017-00185-w
Secondary outcome: anodal tDCS over left DLPFC effects on HPTh and HPTo. Using a mixed 
linear model analysis to compare the Group and Phase, we observed a significant effect of Group related to HPTh, 
F (1; 11.06) = 24.85, P < 0.001, and a significant main effect of Phase, F (3; 11.06) = 6.92, P < 0.001. Also, there 
was an interaction between Group and Phase, F (3; 11.06) = 15.18, P < 0.001. Anodal tDCS over the left DLPFC 
was superior to sham on HPTh increase (irrespective of the Phase). HPTh improved 4.95% after anodal tDCS (the 
mean increase compared to the sham period), considering a pairwise comparison (LSD posthoc).
Also, a mixed model analysis revealed a significant effect of Group on the HPTo, F (1; 51.32) = 3.96, P = 0.03 
and a significant main effect of Phase, F (3; 51.32) = 8.92, P = 0.01. Also, there was an interaction between Group 
and Phase, F (3; 51.32) = 3.34, P = 0.02. HPTo improved 3.6% during sustained heat pain stimulus (Table 4) after 
anodal tDCS (the mean increase compared to the sham period), considering a pairwise comparison (LSD post-
hoc), irrespective of the Phase. The effect of active tDCS compared to sham determined a large size effect on 
HPTh (0.89) and moderate size effect on HPTo (0.53) (Table 4).
Relationship of ANT scores with pain measures and Group. We applied additional analysis to under-
stand the relationship between attentional and pain measures. HPTh was significantly correlated with Executive 
attention in the multivariate linear regression model (Wilks’ λ = 0.81, F = 7.79 P = 0.002, Partial η2 = 0.19). HPTh 
was inversely correlated with Executive, and the effect size was small (Cohen’s f2 = 0.11). Estimators of the asso-
ciation in the multivariate model are presented in Table 5. On the other hand, there was no correlation between 
HPTh and orienting. Although tDCS influences pain and attention in FM, when the effects of tDCS on Executive 
attention is controlled for pain (as indexed by HPTh), there is a small decrease in the coefficient of treatment 
effect. However, this coefficient remained significant, suggesting the effects are mostly independent.
Effects of tDCS on the Go/No-go Task. To clarify training performance and possible effects of tDCS 
along the study, Table 6 presents means and SD according to the main scores of the Go/No-go Task. A mixed 
linear model analysis for each of the scores focusing on Group and Phase factors did not find any significant main 
effects of the conditions (Group or Phase), a no interaction. P values are presented in Table 6.
Variable
s-tDCS + Go/
No-Go first 
(n = 20)
a-tDCS + Go/
No-Go first 
(n = 20)
P 
valueb
Age (years) 51.3 (9.2) 48.7 (9.9) 0.53
Body index weight 
(kg) 28.4 (4.3) 29.6 (7.4) 0.55
Education (years) 8.8 (3.7) 10.7 (4.0) 0.08
Smoking (yes) 5 (20%) 3 (15%) 0.31
Alcohol consumption 
(yes) 5 (25%) 1 (5%) 0.08
Clinical comorbidity 10 (50%) 8 (40%) 0.52
Diagnosis for 
psychiatric disorder 
(yes)a
12 (60%) 14 (70%) 0.45
Scores on BDI-II 25.0 (7.0) 24.0 (8.3) 0.61
Scores on VAS (0 
to100) (cm) 7.31 (2.4) 7.7 (2.1) 0.82
Fibromyalgia Impact 
Questionnaire 64.8 (12.8) 66.8 (13.8) 0.80
Pittsburgh Sleep 
Questionnaire 13.3 (4.3) 11.9 (4.7) 0.32
Pain catastrophizing 
Scale 30.7 (11.8) 32.2 (14.6) 0.66
STAI - State 29.9 (7.8) 27.3 (8.4) 0.31
STAI - Trait 27.9 (5.4) 27.0 (7.2) 0.68
HPTh (°C) 40.8 (2.9) 39.9 (3.2) 0.31
HPTo (°C) 45.5 (2.8) 45.6 (3.1) 0.96
Central nervous 
system active 
medication (yes)
13 (65%) 13 (65%) 0.68
Antidepressant (yes) 10 8 —
Anticonvulsant (yes) 3 1 —
Table 1. Sample Characteristics at Baseline, According to Group and Phase. Values are given as mean (SD) or 
frequency (%) (n = 40). Notes: BDI-II: Back Depression Inventory II; VAS: visual analog scale; STAI: State Trait 
Anxiety Inventory. aBased on the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I). Patients 
could have none or more than one psychiatric disorder. bIndependent samples t-Tests for mean values and Chi-
Square or Fisher’s tests for frequency values.
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Figure 1. Group differences (main effects) on the ANT scores based on mixed linear model analyses. A: 
Alerting. B: Orienting. C: Executive. *P < 0,05.
Target Type Cue Type
s-tDCS a-tDCS P 
valueaM (SE) M (SE)
Congruent target
No cue 694.54 (19.2) 637.65 (19.2) 0.040
Center 672.96 (22.8) 614.14 (22.8) 0.072
Double 651.5 (20.8) 594.12 (20.8) 0.055
Spatial 658.22 (23.5) 579.2 (23.5) 0.020
Incongruent target
No cue 789.1 (21.7) 736.5 (21.7) 0.091
Center 768.7 (22.7) 742.4 (22.7) 0.415
Double 740.9 (24.3) 731.3 (24.3) 0.780
Spatial 709.3 (23.2) 691.3 (23.2) 0.584
Table 2. Reaction Times (RTs) For Each Stimulation Group According to Target Type and Cue Type (n = 35). 
Notes: M = mean; SE = standard error. aMain effects based on mixed linear model analyses.
ANT 
scores
Sham tDCS M 
(SE)
Active tDCS 
M (SE)
Mean 
Difference 
(95% 
Confidence 
interval)
P 
valuea
Alerting 8.98 (29.53) 12.16 (32.30) 3.17 (−4.88 to 11.22) 0.40
Orienting 39.36 (39.51) 53.99 (38.80) 14.63 (0.37 to 18.89) 0.04
Executive 122.98 (36.49) 88.68 (29.25)
−21.00 
(−37.89 to 
− 4.11)
0.01
Table 3. Means and Standard Errors (SE) for the Primary Outcomes (scores of Alerting, Orienting and 
Executive Attention in the ANT) according to Group (a-tDCS + Go/no-Go Task vs. s-tDCS + Go/no-Go Task) 
(n = 35). aValues based on a mixed ANOVA model. Significance level was P < 0.05.
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Discussion
The present findings confirmed our hypotheses that active tDCS over the left DLPFC, as compared to sham, can 
produce significant changes in the performance of a task that is related to three attentional networks. Specifically, 
the data shows that a-tDCS, compared to sham, led to increased performance in the orienting and executive 
attention networks. There was, however, no difference due to tDCS on the alerting attentional network. Regarding 
our secondary outcome – the effects on pain - active tDCS increased HPT and pain tolerance, as compared to 
sham.
Previous studies have found that people with FM show reduced capacity to maintain the endogenous level of 
activation that is necessary to perform a task (reduced speed of processing) and impaired sustained attention, as 
compared to healthy controls27. In fact, people with FM, compared to healthy controls, show impaired perfor-
mances in the ANT, namely impaired executive control, reduced general vigilance (slower reaction times) and 
greater alertness (more errors after a warning cue)28. In this study, data shows that anodal tDCS over the left 
DLPFC combined with a Go/No-go Task can significantly modulate the orienting (increased RTs) and executive 
Pain measures
Sham tDCS M 
(SE)
Active tDCS M 
(SE)
Mean Difference (95% 
Confidence interval) SMD P valuea
HPTh (°C) 38.88 (2.16) 40.81 (2.86) 1.93 (0.7 to 2.5) 0.89 0.03
HPTo (°C) 42.26 (2.86) 43.78 (2.21) 1.52 (0.12 to 2.91) 0.53 0.03
Table 4. Means and Standard Errors (SE) for the Secondary Outcomes (Heat Pain Threshold [HPTh] and Heat 
Pain Tolerance [HPTo]) according to Group (a-tDCS + Go/no-Go Task vs. s-tDCS + Go/no-Go Task) (n = 35). 
aValues based on a mixed ANOVA model. Significance level was P < 0.05.
Dependent Variable
Type III Sum 
of Squares df Mean Square F P Partial η2
ANT Orienting 736.4 2 368.2 0.36 0.70 0.01
ANT Executive 53545.6 2 26772.8 9.23 <0.01 0.23
Β SEM t P Partial η2
ANT Orienting
Intercept 105.42 52.13 2.02 0.04 0.06
s-tDCS −1.28 8.10 −0.15 0.87 <0.01
a-tDCSa . . . . .
HPTh (°C) −1.09 1.29 −0.84 0.40 0.03
s-tDCS*HPTh vs 
a-tDCS*HPTh 4.26 4.98 0.85 0.39 0.02
ANT Executive
Intercept 375.56 87.61 4.29 <0.01 0.23
s-tDCS −48.77 13.61 −3.58 <0.01 0.17
a-tDCSa . . . . .
HPTh (°C) −6.12 2.17 −2.82 0.01 0.11
s-tDCS*HPTh vs 
a-tDCS*HPTh 4.25 4.98 0.85 0.39 0.02
Table 5. Multivariate Regression Model for the Association between ANT and Pain measures and Group 
(a-tDCS + Go/no-Go Task vs. s-tDCS + Go/no-Go Task) (n = 35). Notes: HPTh = Heat Pain Threshold; 
df = degrees of freedom; SEM = standard error of the mean; η2 = eta squared effect size index. aComparative 
group, to which values are referenced to.
Go/No-go Task 
scores
Phase 1 
s-tDCS
Phase 1 
a-tDCS Phase 2 s-tDCS
Phase 2 
a-tDCS
P valueaM (SE) M (SE) M (SE) M (SE)
Proportion of correct 
Go trials (hits) 0.98 (0.01) 0.97 (0.01) 0.98 (<0.01) 0.97 (0.01) 0.744
Proportion of 
incorrect No-go trials 
(false alarms)
0.54 (0.03) 0.58 (0.03) 0.54 (0.04) 0.52 (0.04) 0.444
RTs of Go trials (hits) 438.1 (16.0) 417.9 (16.0) 402.3 (12.8) 403.6 (12.8) 0.462
RTs of incorrect No-
go trials (false alarms) 424.8 (23.2) 425.0 (23.2) 408.9 (20.1) 383.5 (20.1) 0.558
Table 6. Go No-go Task scores according to Group and Phase (n = 35). Notes: s-tDCS = sham stimulation 
group; a-tDCS = active stimulation group; RTs = reaction time (in milliseconds). aRefers to the F statistics for 
the interaction term between Group and Phase. No main effects were found for Group or Phase in any measure.
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(decreased RTs) attentional networks, as assessed by the ANT. Thus, it seems that anodal tDCS is able to improve 
the selection signal from sensory input (orienting), as well as the ability to monitor and solve interferences from 
different inputs and responses (executive), but without inducing any changes in the sensitivity to incoming stim-
uli (alerting)29.
Previous studies showed that subjects with FM have a reduction in their capacity to filter out distracting 
information10. This interference can impair the executive functioning and attention shifting in tasks containing 
a distraction as a competing source of information19, 30. So anodal tDCS seems to impact attention networks 
by a reduction of the cue’s predictive value, but also by improving conflict resolution among incongruent cues. 
Interestingly enough there was no effect on the alert attentional network. This may have happened due to the 
effect on the executive network, as it is thought that alerting network can have an inhibitory effect on the execu-
tive network, leading to faster responses to sensory input (infrequent stimulus) and preventing the system from 
focusing on irrelevant stimuli31.
Although the underlying mechanisms that contribute to cognitive dysfunctions in FM are not entirely 
explained, cognitive impairments seem to be associated with chronic stress related changes in the brain, namely 
hypocortisolism32, hippocampal dysfunction33 and alterations in prefrontal cortical morphology34. This mala-
daptive psychological mechanism of pain processing, as investigated in the present study, has been assumed 
to enhance vulnerability for developing or maintaining disability due to chronic pain. In fact, this finding is 
supported by previous longitudinal studies, which demonstrated that the connectivity between the default mode 
network and insular cortex is correlated with the pain level at the time of the scan35, 36. This hyper-connectivity 
of the insular cortex with regions involved in self-referential cognitions are thought to play a pivotal role on pain 
perception in fibromyalgia35. In the same line, two independent studies showed an association between pain relief 
following treatment with pregabalin and a decrease in the connectivity between the default mode network and 
insular cortex36, 37.
This finding is especially relevant because the DLPFC reflects cognitive-executive control38, but seems also to 
be able to influence the descendent pain modulation system39. Thus, the additive effect of a combined active tDCS 
with a task with inhibitory cues suggests that the activation of neural networks by non-pain related stimulus may 
be a top—down neuromodulatory approach with possible clinical impact for pain relief, as seen by the effect of 
anodal tDCS in the executive attentional network and pain relief. This finding is a potential insight to support the 
idea of using active tDCS combined with pharmacological intervention40 or conscious distraction41 in order to 
improve the treatment effects of fibromyalgia.
The active tDCS increases the HPT and pain tolerance (Table 5). This finding is supported by an extensive 
number of studies using tDCS to decrease pain42–44. Although the most common site of stimulation to treat pain 
has been the motor cortex (M1)45, the data from the present study suggests that anodal tDCS over the left DLPFC 
might affect sensory-discriminative pain processing, which in turn induces pain relief. This effect on pain relief 
has already been reported following tDCS over the left DLPFC46. Moreover, the involvement of the DLPFC on 
pain analgesia has been already well documented According to previous studies, the DLPFC is though to be 
involved in placebo analgesia in downstream circuits to the anterior insula, ACC, hypothalamus and the PAG47, 48. 
What is not known is how anodal tDCS over the Left DLPFC can induce pain relief. One hypothesis is that tDCS 
over the DLPFC increases connectivity across brain regions49, 50. For instance, tDCS over M1 may increase the 
activity of insula and thalamus51, 52. Moreover, anodal tDCS over M1 increases functional coupling between ipsi-
lateral M1 and thalamus53. Thus, one hypothesis is that the analgesic effects observed after the DLPFC stimulation 
may be least partially attributable to an indirect inhibitory modulation of thalamic activity, that well result in the 
alleviation of the painful experience after stimulation of the DLPFC46.
Nonetheless, there are some potential limitations in the present design. A uniform dose of stimulation was 
used for all subjects, and this may not be the most efficient procedure54. Also, we included only females because 
they are more prone to activation upon negative emotional responses (i.e., stress, fear, and anxiety). Thus, in 
this context, the gender may be a significant confounding factor. Also, there is no control group. We chose a 
crossover design, because it will allow us to have subjects serving as their own controls, thus reducing variability 
when assessing outcomes related to behavior and physiological parameters43. And finally, although the present 
findings are important to understand the possible neurobiological mechanisms underlying the effects of tDCS 
over DLPFC in combination combined with go/no-go task in attention networks and pain modulation, they 
do not provide enough evidence in order to guide decision making in clinical settings. However, future studies 
should test the addictive effects of repetitive sessions of tDCS, especially in these types of chronic conditions. 
For instance, another study using tDCS with fibromyalgia patients showed that the median number of sessions 
required to induce a clinically meaningful effect was 1555.
Conclusion
Overall, our results highlight two important conclusions. First, one session of anodal tDCS over the left DLPFC 
has a modulatory effect on the orienting and executive attentional networks, as assessed by the performance of the 
ANT. The secondary effect in pain could reflect an active control of pain perception in a top-down manner. Also, 
these findings suggest that the effect of tDCS on pain and attention may be a major target for neurostimulation 
therapies in addition to or in combination with the primary motor cortex for subjects who do not respond or are 
more refractory to neurostimulation therapies.
Methods
Design overview, settings and participants. The methods and results sections are reported accord-
ing to the CONSORT guidelines. All subjects provided written informed consent before participating in this 
randomized, crossover blind, clinical trial with allocation ratio of 1:1. The study followed the guidelines and 
regulations for clinical research and was approved by the Research Ethics Committee at the Hospital de Clínicas 
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de Porto Alegre (HCPA) (Institutional Review Board IRB 140231).The current controlled trial is registered at 
ClinicalTrials.gov under number NCT02454218 (First received: January 19, 2015).
We recruited 40 adult from 18 to 65 years-old female outpatients of the HCPA and via advertisement. Sample 
size was calculated based on previous findings, with 0.8 effect size (Cohen’s D) magnitude (SD = 0.6), alpha level 
of 0.01 and 80% power. FM was diagnosed according to American College of Rheumatology criteria56. Subjects 
were required to have a score of at least 50 mm on the 0–100 mm visual analogue scale for pain (VAS, which 0 
means “no pain” and 100 means “worst possible pain”) during most of the days over the last three months57. 
Subjects were allowed to remain on analgesic medications, including drugs for which they were refractory, and 
these medications could not be adjusted during the study. Major depressive disorder was accepted as secondary 
to FM. Subjects with history of substance abuse or evidence of other pain-related disorder were excluded. Females 
pregnant, in breast-feeding, or with a history of neurologic or oncologic disease, ischemic heart disease, kidney or 
hepatic insufficiency were also excluded.
Intervention: Online combined tDCS stimulation and Go/No-go Task. tDCS was applied by a 
Research Limited stimulator (TCT, Hong Kong, China) using 35 cm2 saline-soaked electrode sponges. Each tDCS 
session started with 3 minutes46 of stimulation applied to each subject prior to execution of the computerized Go/
No-Go task58. This interval was used because it has been reported to be the minimum amount of time required 
for tDCS to elicit after-effects49. Subjects were randomly assigned to receive two sessions of tDCS (anodal a-tDCS 
and sham) over the left DLPFC. The active electrode (anode, 35 cm2) was placed over the left DLPFC [F3, 10–20 
system], and the return electrode (cathode, 35 cm2) was placed on the contralateral supraorbital area (FP2 site). 
tDCS was applied with 1 mA intensity, for a total of 20 minutes, with a 30-s ramp up and down. Sham started with 
a 15-s ramp up and immediately 15 s ramp down), with no current flowing after this.
All tasks were presented using E-Prime version 2.0 SP1 software (Psychology Software tools, Sharpsburg PA, 
US). Stimuli were presented on the center of screen with approximately 2.0° of visual angle (viewing distance 
approximately 60 cm). The Go/No-go Task is a simple choice reaction paradigm that requires response inhibition 
when one of two stimuli is presented (go versus no-go). On the center of the screen, subjects were shown a fixa-
tion cross (1000 ms) followed by a go letter (e.g., “L”, “Q”, “B”, etc.) or a no-go letter (e.g. “X”) for 500 ms each and 
were instructed to press the “space” key as fast as possible for the go letters. They were required to not press any 
Figure 2. Attention network test (ANT); cues: no cue, central cue, double cue and spatial cues; and targets: 
Incongruent, neutral and congruent and an example of the procedure of ANT. Left column: sequence of events 
per trial of the ANT; right column: possible stimuli associated with each event. Except for the spatial and invalid 
spatial cue (80% vs. 20% probability, respectively), all cue and flanker constellations were equally probable 
and appeared up or down of the fixation cross. The target and flanker remained visible on the screen until the 
patients respond, but for no longer than 1700 ms. While trial duration was fixed to 4000 ms, a temporal jitter was 
introduced by a variable delay of the cue onset (200, 300, and 400 ms after trial onset) to reduce expectancies.
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key for the no-go letters. There were three blocks, each with a different no-go letter (“H”, “X” and “K”) to avoid 
learning (no-go letters were never presented as a go letter), with a total of 339 go trials and 78 no-go trials. Total 
task time was 17 minutes.
Randomization. We used a simple randomization method via Randomization.com, which relies on inde-
pendent and equal probabilities to receive each intervention for each subject. Although it is the most basic 
approach, it preserves unpredictability of the allocation. The software generated a random number, for which one 
of the interventions was randomly allocated. In this way, it was guaranteed that each subject had the same chance 
of receiving one of the interventions (active or sham) first.
Blinding. Subjects were instructed to discuss all aspects related to their tDCS intervention only with the per-
son responsible for the tDCS application (rather than the person responsible for the assessments)44. Allocation 
concealment was assured by intervention being assigned only after enrollment. Furthermore, to assess whether 
blinding was effective, at the end of the experiment subjects were asked to guess whether they had received 
a-tDCS or sham and to rate their confidence level using a 5-point Likert scale (from no confidence at all to com-
pletely confident).
Baseline instruments and assessments. All psychological tests used have been validated for the 
Brazilian population. Two independent medical examiners, who were blinded to the group assignments were 
trained to conduct the psychological tests and administer the pain scales. At the baseline, the instruments used 
were: Pittsburgh Sleep Quality Index59 to assess the sleep quality; Beck Depression Inventory-II (BDI-II60), for 
the assessment of depressive symptoms; Mini-International Neuropsychiatric Interview (M.I.N.I.61) to detect 
psychiatric disorders; The Brazilian validated version of the Fibromyalgia Impact Questionnaire (FIQ62), to assess 
quality of life of FM patients; and the Brazilian Portuguese version of the Pain Catastrophizing Scale (B-PCS63), 
for the catastrophic thinking. Medical comorbidities and demographic data were assessed using a standardized 
questionnaire. To evaluate the safety of tDCS, we used the Systematic Assessment for Treatment with tDCS ques-
tionnaire based on previously reported adverse events64.
Outcomes. The primary outcome was the effects of the intervention on the performance of the ANT, based 
on the scores of Alerting, Orienting, and Executive attention. Secondary outcomes were the temperature reported 
for the heat pain threshold (HPTh) and heat pain tolerance (HPTo).
Attention Network Test (primary outcomes). The ANT65 was used to assess the attention networks performance. 
A target (i.e. arrows) pointing left or right appeared on the center of the screen for 1700 ms right after a cue, 
which lasted for 100 ms (i.e. asterisk). The ANT is a combination of a cued reaction time task with the flanker test. 
Figure 3. Flowchart showing recruitment and progress through the study.
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Therefore, the test had four Cue (warning) conditions (no cue, central cue, double cue and spatial cue) and the 
three Target (flanker) conditions (congruent, incongruent and neutral); see Fig. 2 for a detailed view.
All combinations of conditions (cue and target) were randomly presented in one block of 96 test trials. 
Twenty-four practice trials were performed before the test trials. Subjects were asked to identify the direction to 
which the center arrow pointed as soon as possible. Based on cue and target conditions, three main indices were 
calculated. The Alerting attention was calculated by subtracting the mean response time (RT) of the double-cue 
conditions from the mean RT of the no-cue conditions. The Orienting attention was calculated by subtracting the 
mean RT of the spatial cue conditions from the mean RT of the center cue. For these two measures, the higher the 
score, the better the participant’s attentional processing. Finally, the Executive (conflict) attention was calculated 
by subtracting the mean RT of all congruent flanking conditions from the mean RT of incongruent conditions65. 
For this measure, the lower the score, the better the participant dealt with interference. Scores over 2 standard 
deviations from the mean were removed (which represents less than 5% of the total number of scores).
Pain measures (secondary outcomes). Pain was assessed using a computer Peltier-based device thermode 
(30 × 30 mm)66. The thermode was attached to the skin on the ventral aspect of the mid-forearm, with tem-
perature increasing 1 °C/s, from 32 °C to a maximum of 52 °C (for safety reasons, after which the device cooled 
down). The heat primarily stimulates C-nociceptive afferent pathways67. Using the methods of limits, the par-
ticipants were asked to press a button with the thumb as soon as they feel the stimulus as painful. Three assess-
ments were performed with an interstimuli interval of 40 s, with position of the thermode being slightly altered 
(approx. 30 mm) to avoid sensitization or response suppression. The average of those assessments is the Heat Pain 
Threshold (HPTh). Heat Pain Tolerance (HPTo) temperature was determined by asking subjects to press a button 
as soon as the sensation of pain had reached the maximum they could tolerate. In case 52 °C was the subject’s 
maximum temperature, the HPTo was considered unknown.
General Procedure. Participants initially volunteered by signing the consent form. Following this, they 
responded to the baseline assessments and were checked for necessary exclusion criteria. Then, they were ran-
domly allocated to one of the experimental groups, either receiving sham stimulation first (Sham-Active Group) 
or active stimulation first (Active-Sham Group). Measures of attention through the ANT were obtained after 
each phase of tDCS, with a 1-week interval between each phase. Blinding was also incorporated and side effects 
following tDCS were recorded. Heat pain measures were assessed before and after each phase, although only after 
measures were analyzed here. Data was collected in acclimatized rooms of the Clinical Research Center in the 
hospital. Figure 3 presents the flowchart of the study.
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